The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Dopamine receptors and transporters in Parkinson's disease and schizophrenia
Abstract
The loss of midbrain dopamine in Parkinson's disease is accompanied by a matching loss in the dopamine transporter and a rise in the D1 and D2 receptor densities. This is found in the brain putamen and caudate tissues from unmedicated patients, and may account for the good early clinical response to l ‐dopa. Long‐term l ‐dopa treatment reverts the receptor densities toward normal levels. Positron emission tomography (PET) data and in vitro data generally concur. In schizophrenia the density of the dopamine transporter as well as that of the D1 dopamine receptor is normal. The D2 receptor density, however, is consistently elevated in postmortem brain putamen and caudate nucleus, even in tissues from neuroleptic‐free or drug‐naive patients. Three sets of PET and single photon emission computed tomography (SPECT) data support the postmortem findings. Early evidence indicating abnormal D2 structure as well as a reduced link between D1 and D2 warrant a detailed study of the genes for these two receptors in schizophrenia.—S eeman , P.; N iznik , H. B. Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J. 4: 2737‐2744; 1990.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
Kish, S. J., Shannak, K., & Hornykiewicz, O. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804073181402 · Cited by 1,953
Cloning and expression of a rat D2 dopamine receptor cDNA
Bunzow, J. R., Tol, H. H. M. V., Grandy, D. K., Albert, P., Salon, J., Christie, M., Machida, C. A., Neve, K. A., & Civelli, O. (1988) · Nature · doi:10.1038/336783a0 · Cited by 1,117
Positron Emission Tomography Reveals Elevated D 2 Dopamine Receptors in Drug-Naive Schizophrenics
Wong, D. F., Wagner, H. N., Tune, L. E., Dannals, R. F., Pearlson, G. D., Links, J. M., Tamminga, C. A., Broussolle, E. P., Ravert, H. T., Wilson, A. A., et al. (1986) · Science · doi:10.1126/science.2878495 · Cited by 932
Dopamine receptors and the dopamine hypothesis of schizophrenia
Seeman, P. (1987) · Synapse · doi:10.1002/syn.890010203 · Cited by 880
Self-citationFarde, L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810150013003 · Cited by 530
INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIA
Owen, F., Crow, T. J., Poulter, M., Cross, A. J., Longden, A., & Riley, G. J. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91740-3 · Cited by 518
Receptor basis for dopaminergic supersensitivity in Parkinson's disease
LEE, T., SEEMAN, P., RAJPUT, A., FARLEY, I. J., & HORNYKIEWICZ, O. (1978) · Nature · doi:10.1038/273059a0 · Cited by 446
Self-citationIncreased Brain Dopamine and Dopamine Receptors in Schizophrenia
Mackay, A. V. P. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290090001001 · Cited by 397
Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization
German, D. C., Manaye, K., Smith, W. K., Woodward, D. J., & Saper, C. B. (1989) · Annals of Neurology · doi:10.1002/ana.410260403 · Cited by 396
Bimodal Distribution of Dopamine Receptor Densities in Brains of Schizophrenics
Seeman, P., Ulpian, C., Bergeron, C., Riederer, P., Jellinger, K., Gabriel, E., Reynolds, G. P., & Tourtellotte, W. W. (1984) · Science · doi:10.1126/science.6147018 · Cited by 349
Self-citationSEEMAN, P. (1987) · Neuropsychopharmacology · doi:10.1016/0893-133x(87)90004-2 · Cited by 316
Self-citationSeeman, P., Guan, H. ‐., & Niznik, H. B. (1989) · Synapse · doi:10.1002/syn.890030113 · Cited by 293
Self-citationDecreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics
Mita, T., Hanada, S., Nishino, N., Kuno, T., Nakai, H., Yamadori, T., Mizoi, Y., & Tanaka, C. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90332-x · Cited by 222
Elevation of brain neuroleptic/dopamine receptors in schizophrenia
(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.2.191 · Cited by 219
[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy
Bokobza, B., Ruberg, M., Scatton, B., Javoy-Agid, F., & Agid, Y. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90238-3 · Cited by 210
Niznik, H. B., Tyndale, R. F., Sallee, F. R., Gonzalez, F. J., Hardwick, J. P., Inaba, T., & Kalow, W. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90741-g · Cited by 191
Self-citationLink between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
Seeman, P., Niznik, H. B., Guan, H. C., Booth, G., & Ulpian, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10156 · Cited by 191
Self-citationToru, M., Watanabe, S., Shibuya, H., Nishikawa, T., Noda, K., Mitsushio, H., Ichikawa, H., Kurumaji, A., Takashima, M., Mataga, N., et al. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06312.x · Cited by 191
Kornhuber, J., Riederer, P., Reynolds, G. P., Beckmann, H., Jellinger, K., & Gabriel, E. (1989) · Journal of Neural Transmission · doi:10.1007/bf01250639 · Cited by 189
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.1.44 · Cited by 172
Joyce, J. N., Lexow, N., Bird, E., & Winokur, A. (1988) · Synapse · doi:10.1002/syn.890020511 · Cited by 167
Cross, A. J., Crow, T. J., & Owen, F. (1981) · Psychopharmacology · doi:10.1007/bf00432676 · Cited by 164
Biochemistry of Parkinson's disease 28 years later: A critical review
Agid, Y., Cervera, P., Hirsch, E., Javoy-Agid, F., Lehericy, S., Raisman, R., & Ruberg, M. (1989) · Movement Disorders · doi:10.1002/mds.870040514 · Cited by 163
Schoemaker, H., Pimoule, C., Arbilla, S., Scatton, B., Javoy-Agid, F., & Langer, S. Z. (1985) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00501873 · Cited by 162
Dopamine receptor subtype imbalance in schizophrenia
Hess, E. J., Bracha, H. S., Kleinman, J. E., & Creese, I. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90381-x · Cited by 139
[3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease
Pimoule, C., Schoemaker, H., Reynolds, G. P., & Langer, S. Z. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90634-x · Cited by 122
Behavioral effects of l-Dopa in schizophrenic patients
ANGRIST, B. M., Sathananthan, G., & Gershon, S. (1973) · Psychopharmacology · doi:10.1007/bf00429294 · Cited by 119
Cortés, R., Camps, M., Gueye, B., Probst, A., & Palacios, J. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)90031-0 · Cited by 109
Hägglund, J. V., Sm, A., Eckernas, S., Hartvig, P., Lundquist, H., Gullberg, P., & Långström, B. (1987) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1987.tb07900.x · Cited by 108
Dopamine receptors in the parkinsonian brain
Rinne, U. K., Lönnberg, P., & Koskinen, V. (1981) · Journal of Neural Transmission · doi:10.1007/bf01664007 · Cited by 104
DOPAMINE D2 RECEPTORS IN SCHIZOPHRENIA STUDIED IN VIVO
Crawley, J. C. W., Crow, T. J., Johnstone, E. C., Oldland, S. R. D., Owen, F., Owens, D. G. C., Poulter, M., Smith, T., Veall, N., & Zanelli, G. D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92525-0 · Cited by 93
Alterations in dopaminergic receptors in Huntington's disease
Reisine, T., Fields, J. Z., Stern, L. Z., Johnson, P. C., Bird, E. D., & Yamamura, H. I. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90111-4 · Cited by 89
Janowsky, A. J., Vocci, F. J., Berger, P. A., Angel, I., Zelnik, N., Kleinman, J. E., Skolnick, P., & Paul, S. M. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb02908.x · Cited by 88
Tedroff, J., Aquilonius, S., Hartvig, P., Lundqvist, H., Gee, A. D., Uhlin, J., & Långström, B. (1988) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1988.tb05894.x · Cited by 88
Maloteaux, J., Vanisberg, M.-A., Laterre, C. E., et al. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90278-6 · Cited by 85
Dopamine Uptake Sites and Dopamine Receptors in Parkinson’s Disease and Schizophrenia
Pearce, R. K. B., Seeman, P. M., Jellinger, K., & Tourtellotte, W. W. (2008) · European Neurology · doi:10.1159/000117168 · Cited by 72
Self-citationHIRAI, M., Kitamura, N., Hashimoto, T., NAKAI, T., Mita, T., Shirakawa, O., Yamadori, T., Amano, T., NOGUCHI-KUNO, S. A., & Tanaka, C. (1988) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.47.237 · Cited by 54
Cloning of two additional catecholamine receptors from rat brain
O’Dowd, B. F., Nguyen, T., Tirpak, A., Jarvie, K. R., Israel, Y., Seeman, P. M., & Niznik, H. B. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80140-e · Cited by 50
Self-citationTracing of dopamine receptors in hemiparkinsonism with positron emission tomography (PET)
Rutgers, A. W. F., Lakke, J. P. W. F., Paans, A. M. J., Vaalburg, W., & Korf, J. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90158-4 · Cited by 39
Dopamine receptor changes in schizophrenia in relation to the disease process and movement disorder.
Cross, A. J., Crow, T. J., Ferrier, I. N., Johnstone, E. C., McCreadie, R. M., Owen, F., Owens, D. G. C., & Poulter, M. (1983) · PubMed · Cited by 38
[3H] GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophrenia
Czudek, C., & Reynolds, G. P. (1989) · Journal of Neural Transmission · doi:10.1007/bf01248935 · Cited by 31
Status of the dopaminergic system in post-mortem brain in schizophrenia.
Reynolds, G. P., & Czudek, C. (1988) · PubMed · Cited by 22
Brain Dopamine Receptors in Schizophrenia: PET Problems
Seeman, P. M. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800300096017 · Cited by 21
Self-citationBRAIN DOPAMINE RECEPTORS IN SCHIZOPHRENIA
Lee, T., & Seeman, P. M. (1982) · Elsevier eBooks · doi:10.1016/b978-0-08-027987-9.50027-5 · Cited by 13
Self-citationMartinot, J. L., Huret, J. D., Péron-Magnan, P., Mazoyer, B. M., Baron, J., Caillard, V., Syrota, A., & Lôo, H. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90088-7 · Cited by 12
Cited by
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1
Sunahara, R. K., Guan, H.-C., O'Dowd, B. F., Seeman, P., Laurier, L. G., Ng, G., George, S. R., Torchia, J., Van Tol, H. H. M., & Niznik, H. B. (1991) · Nature · doi:10.1038/350614a0 · Cited by 1,165
Self-citationModeling Parkinson's Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal Pathway
Deumens, R., Blokland, A., & Prickaerts, J. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7891 · Cited by 758
Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors
Baik, J.-H., Picetti, R., Saiardi, A., Thiriet, G., Dierich, A., Depaulis, A., Le Meur, M., & Borrelli, E. (1995) · Nature · doi:10.1038/377424a0 · Cited by 650
A neurobiological basis for substance abuse comorbidity in schizophrenia
Chambers, R. A., Krystal, J. H., & Self, D. W. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01134-9 · Cited by 548
Emerging principles of altered neural circuitry in schizophrenia
Benes, F. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00041-7 · Cited by 513
Metadata
- Authors
- Seeman, P., & Niznik, H. B.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1990-07
- Volume
- 4
- Issue
- 10
- Pages
- 2737-2744
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2119478024
- Cited by
- 300
- References
- 45
- FWCI
- 18.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.